Data / Form D filings / Interius BioTherapeutics, Inc.
Interius BioTherapeutics, Inc.: Form D filings
Interius BioTherapeutics, Inc., a biotechnology company in Philadelphia, PA, filed 4 Form D notices with the SEC between 2020 and 2024. The latest, on June 3, 2024, reports $51.4 million sold of a $82.5 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3401 GRAYS FERRY AVENUE, BUILDING 200, SUITE 300, Philadelphia, PA, 19146
- Phone
- (215) 608-9333
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1807811
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | New notice | $82,509,197 | $51,432,536 | $31,076,661 | 12 | May 21, 2024 | sec.gov |
| Oct 20, 2023 | New notice | $21,451,331 | $21,451,331 | 13 | Oct 5, 2023 | sec.gov | |
| May 27, 2021 | New notice | $76,344,951 | $43,625,657 | $32,719,294 | 25 | May 14, 2021 | sec.gov |
| Mar 27, 2020 | New notice | $3,150,000 | $1,575,000 | $1,575,000 | 5 | Mar 13, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Leon O. Moulder | Director | |
| Tomas R. Kiselak | Director | |
| Bihua O. Chen | Director | |
| Leon R. Moulder, Jr. | Director | |
| Dora R. Mitchell | Executive Officer | |
| Philip R. Johnson, M.D. | Executive Officer, Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jun 3, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Interius BioTherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.